Enzolytics (Enzolytics) Total Liabilities : $0.80 Mil (As of Jun. 2011)

View and export this data going back to 2008. Start your Free Trial

What is Enzolytics Total Liabilities?

Enzolytics's Total Liabilities for the quarter that ended in Jun. 2011 was $0.80 Mil.

Enzolytics's quarterly Total Liabilities increased from Dec. 2010 ($0.73 Mil) to Mar. 2011 ($0.80 Mil) and increased from Mar. 2011 ($0.80 Mil) to Jun. 2011 ($0.80 Mil).

Enzolytics's annual Total Liabilities increased from Jul. 2008 ($0.08 Mil) to Dec. 2009 ($1.41 Mil) but then declined from Dec. 2009 ($1.41 Mil) to Dec. 2010 ($0.73 Mil).

Enzolytics Total Liabilities Historical Data

The historical data trend for Enzolytics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzolytics Total Liabilities Chart

Enzolytics Annual Data

Trend

Dec07

Jul08

Dec09

Dec10

Total Liabilities

0.44

0.08

1.41

0.73

Enzolytics Quarterly Data
	Sep07	Dec07	Apr08	Jul08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11
Total Liabilities	Get a 7-Day Free Trial										1.90	2.02	0.73	0.80	0.80

Enzolytics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Enzolytics's Total Liabilities for the fiscal year that ended in Dec. 2010 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.677	+	(0.048	+	-6.9388939039072E-17
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.73

Total Liabilities	=	Total Assets (A: Dec. 2010 )	-	Total Equity (A: Dec. 2010 )
	=	0.153	-	-0.572
	=	0.73

Enzolytics's Total Liabilities for the quarter that ended in Jun. 2011 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.778	+	(0.024	+	0.001
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	0.80

Total Liabilities	=	Total Assets (Q: Jun. 2011 )	-	Total Equity (Q: Jun. 2011 )
	=	0.112	-	-0.691
	=	0.80

Enzolytics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Enzolytics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzolytics (Enzolytics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzolytics Inc (OTCPK:ENZC) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013

Website

https://www.enzolytics.com

Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.